{"id":"W2037559535","doi":"10.1097/cco.0b013e3282f335a3","title":"Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes","year":2008,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Exelixis","keywords":"Erlotinib; Gefitinib; Medicine; Lung cancer; Epidermal growth factor receptor; Tyrosine kinase; Erlotinib Hydrochloride; Tyrosine-kinase inhibitor; Monoclonal antibody; Docetaxel; Cancer research; Bevacizumab; EGFR inhibitors; Clinical trial; Oncology; Pharmacology; Cancer; Internal medicine; Receptor; Antibody; Immunology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009261941,0.0003124847,0.001550203,0.0002700076,0.00004428597,0.000004958165,0.00008688935,0.0002372301,0.00003958978],"category_scores_gemma":[0.00004625183,0.0001817793,0.0002208368,0.0003267523,0.0001457132,0.00004006797,0.00002203964,0.0002499008,0.000002337091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001633603,"about_ca_system_score_gemma":0.001247093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009809543,"about_ca_topic_score_gemma":0.00008759413,"domain_scores_codex":[0.9980764,0.000389684,0.0007706592,0.0003729476,0.0001509522,0.0002393504],"domain_scores_gemma":[0.9988527,0.0004294834,0.0003715922,0.0002192931,0.00005159516,0.00007530606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002829935,0.001203348,0.006707609,0.006866653,0.0001427332,0.000006303138,0.002100474,2.487869e-7,5.35483e-8,0.00007409105,0.006588626,0.9762816],"study_design_scores_gemma":[0.001756631,0.0007104466,0.002820612,0.007167257,0.0003089854,0.00004647146,0.00004798878,0.000002430753,5.290337e-7,0.000006383593,0.987003,0.0001292821],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003582879,0.9932936,0.000001386169,0.000836906,0.002773106,0.002240388,0.0003091952,0.00001040508,0.0001766684],"genre_scores_gemma":[0.0001229619,0.9974471,0.00002616428,0.00001706176,0.0006199784,0.00122005,0.0005065388,0.00001955245,0.0000206338],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9804143,"threshold_uncertainty_score":0.7412744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1319367048533914,"score_gpt":0.5022138484156957,"score_spread":0.3702771435623043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}